Characteristics | Full Cohort, n = 970 | White, n = 141 (15) | African American, n = 410 (42) | Latino, n = 265 (27) | Other, n = 154 (16) | p |
---|---|---|---|---|---|---|
Age, yrs, mean (SD) | 14.7 (2.0) | 15.0 (1.8) | 14.8 (2.0) | 14.4 (2.0) | 14.3 (2.0) | < 0.01 |
Female | 805 (83) | 120 (85) | 337 (82) | 220 (83) | 128 (83) | 0.89 |
Location | < 0.01 | |||||
Urban | 822 (85) | 108 (77) | 346 (84) | 244 (92) | 124 (81) | |
Rural | 148 (15) | 33 (23) | 64 (16) | 21 (8) | 30 (19) | |
SLE nephritis | 345 (36) | 34 (24) | 149 (36) | 93 (35) | 69 (45) | < 0.01 |
Seizures/stroke | 155 (16) | 24 (17) | 70 (17) | 22 (14) | 22 (14) | 0.77 |
Glucocorticoid use | 821 (85) | 107 (76) | 361 (88) | 225 (85) | 128 (83) | < 0.01 |
Outpatient visits, median (IQR) | 15 (9–23) | 14 (10–25) | 15 (8–24) | 15 (8–23) | 16 (10–23) | 0.62 |
SLE: systemic lupus erythematosus; IQR: interquartile range.